Will you use FeNO testing in all COPD patients to determine whether they are candidates for therapy with dupilumab?
If so, would this be a consideration in all patients regardless of active smoking status? FeNO in active smokers has been questioned, could this have accounted for the difference seen in treatment response of patients with higher or lower FeNO in the BOREAS trial?
Community PollStarted
Do you use FeNO testing in patients with COPD to determine candidacy for therapy with dupilumab?
25 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Pulmonology · Columbia Doctors Pulmonology
Answered on
I suspect high eosinophils will be used more often.
Join for free or sign in to see the full answer
Mednet Member
Pulmonology · Mount Sinai School of Medicine
Answered on
Yes, I already do this.
Join for free or sign in to see the full answer